Inspire Medical Systems, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Inspire Medical Systems, Inc. (INSP) reported Cash and Cash Equivalents, Period Increase (Decrease) of $4.66 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-07.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-07
- Inspire Medical Systems, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $4.66M, a 112.45% increase year-over-year.
- Inspire Medical Systems, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was $70.98M.
- Inspire Medical Systems, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$95.54M.
- Inspire Medical Systems, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $110.71M.
- Inspire Medical Systems, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $88.33M, a 3791.32% increase from fiscal 2017.
- Inspire Medical Systems, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $2.27M.
- Inspire Medical Systems, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$5.44M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-03-31 | $4.66M 10-Q · filed 2019-05-07 | $75.63M derived: sum of 2 quarters · filed 2019-05-07 | -$19.91M derived: sum of 3 quarters · filed 2019-05-07 | $90.80M derived: sum of 4 quarters · filed 2019-05-07 |
| 2018-12-31 | $70.98M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$24.57M derived: sum of 2 quarters · filed 2019-02-26 | $86.14M derived: sum of 3 quarters · filed 2019-02-26 | $88.33M 10-K · filed 2019-02-26 |
| 2018-09-30 | -$95.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $15.16M derived: sum of 2 quarters · filed 2018-11-06 | $17.36M 10-Q · filed 2018-11-06 | $11.77M derived: sum of 4 quarters · filed 2019-05-07 |
| 2018-06-30 | $110.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $112.90M 10-Q · filed 2018-08-07 | $107.31M derived: sum of 3 quarters · filed 2019-05-07 | $99.35M derived: sum of 4 quarters · filed 2019-05-07 |
| 2018-03-31 | $2.19M 10-Q · filed 2019-05-07 | -$3.39M derived: sum of 2 quarters · filed 2019-05-07 | -$11.36M derived: sum of 3 quarters · filed 2019-05-07 | -$15.40M derived: sum of 4 quarters · filed 2019-05-07 |
| 2017-12-31 | -$5.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$13.55M derived: sum of 2 quarters · filed 2019-02-26 | -$17.60M derived: sum of 3 quarters · filed 2019-02-26 | $2.27M 10-K · filed 2019-02-26 |
| 2017-09-30 | -$7.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$12.01M derived: sum of 2 quarters · filed 2018-11-06 | $7.86M 10-Q · filed 2018-11-06 | |
| 2017-06-30 | -$4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $15.82M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $19.87M 10-Q · filed 2018-06-07 | |||
| 2016-12-31 | -$5.44M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |